India's top health research body is reviewing its treatment guidelines for Covid-19 and may drop hydroxychloroquine (HCQ) from the protocol due to increasing doubt over its effectiveness, people in the know told ET.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TjIeu1
via IFTTT
0 comments:
Post a Comment